CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity.
about
Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.Peptide and protein-based inhibitors of HIV-1 co-receptorsLead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine.Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicineTargeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokinesProtein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction.Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.Development of peptide inhibitors of HIV transmission.
P2860
Q27309182-8F970A71-99A0-4671-B6E0-1150F1ECE2D5Q30352117-8E3D1CED-8213-4629-907E-A8B1E784746AQ33615005-064695BF-2CF9-4C5F-81F7-6A43DDA41280Q33791008-A83E9E26-381B-4961-ACBD-2510F885A605Q33846502-BCD9A564-1D8D-487B-A041-CEBF792A3DBBQ36915528-B61D685D-C7FA-432F-B5B4-6D9B49F289BFQ38574172-2E6AA392-5BFB-4B4F-8FD2-659A237C0AF7Q40151022-4B11F4BE-25FC-4546-B955-11360895CA32Q55317261-B8B041A2-6C6B-401D-80B2-42D9047D0015
P2860
CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CCR5 mutations distinguish N-t ...... st versus antagonist activity.
@ast
CCR5 mutations distinguish N-t ...... st versus antagonist activity.
@en
type
label
CCR5 mutations distinguish N-t ...... st versus antagonist activity.
@ast
CCR5 mutations distinguish N-t ...... st versus antagonist activity.
@en
prefLabel
CCR5 mutations distinguish N-t ...... st versus antagonist activity.
@ast
CCR5 mutations distinguish N-t ...... st versus antagonist activity.
@en
P2093
P2860
P356
P1433
P1476
CCR5 mutations distinguish N-t ...... st versus antagonist activity.
@en
P2093
Bernard Lagane
Donald E Mosier
Mia Coetzer
Oliver Hartley
Philippe Colin
Rebecca Nedellec
Robin E Offord
Won-Tak Choi
P2860
P304
10218-10220
P356
10.1128/JVI.00353-12
P407
P577
2012-07-11T00:00:00Z